Calithera Biosciences Inc (CALA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The companys product pipeline includes CB-839, a glutaminase inhibitor in tumor metabolism to treat solid tumors; NCB001158, a small molecule arginase inhibitor based on tumor immunology technology that activates the bodys own immune system to attack and kill cancer cells for the treatment of hematology and oncology diseases; CB-280, a arginase inhibitor used for treating Cystic Fibrosis; CB-708, a CD73 inhibitor against immuno-oncology condidtions. The company works in collaboration with bio-pharmaceutical companies such as Incyte Corp, Bristol-Myers Squibb (BMS), and Mars Symbiosciences Inc. Calithera is headquartered in South San Francisco, California, the US.

Calithera Biosciences Inc (CALA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Calithera Biosciences Raises USD14.5 Million in Venture Financing 10
Calithera Biosciences Raises USD16 Million in Venture Financing 11
Calithera Biosciences Raises US$35 Million In Series D Financing 12
Calithera Biosciences Raises US$2 Million In Series C Financing 14
Calithera Biosciences Raises Additional US$4 Million In Series B Financing 15
Partnerships 17
Calithera Biosciences Enters into Partnership with Pfizer 17
Bristol-Myers Squibb and Calithera Biosciences Expand Agreement 18
ProTrials Research Enters into Agreement with Calithera Biosciences 19
Licensing Agreements 20
Incyte Enters into Licensing Agreement with Calithera Biosciences 20
Calithera Biosciences Enters into Licensing Agreement with Mars Symbioscience 22
Equity Offering 23
Calithera Biosciences to Raise up to USD50 Million in Public Offering of Shares 23
Calithera Biosciences Raises USD38 Million in Public Offering of Shares 24
Calithera Biosciences Raises USD80.5 Million in Public Offering of Shares 25
Calithera Biosciences Raises USD8 Million in Private Placement of Shares 27
Calithera Biosciences Raises USD80 Million in IPO 29
Calithera Biosciences Inc - Key Competitors 31
Calithera Biosciences Inc - Key Employees 32
Calithera Biosciences Inc - Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 07, 2018: Calithera Biosciences reports second quarter 2018 financial results and recent highlights 34
May 10, 2018: Calithera Biosciences Reports First Quarter 2018 Financial Results and Recent Highlights 36
Mar 08, 2018: Calithera Biosciences ReportsFourth Quarter 2017 Financial Results and Recent Highlights 38
Nov 02, 2017: Calithera Biosciences Reports Third Quarter 2017 Financial Results and Recent Highlights 40
Aug 08, 2017: Calithera Biosciences Reports Second Quarter 2017 Financial Results and Recent Highlights 41
May 09, 2017: Calithera Biosciences Reports First Quarter 2017 Financial Results and Recent Highlights 42
Mar 16, 2017: Calithera Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Highlights 44
Corporate Communications 46
Oct 03, 2017: Calithera Biosciences Announces Appointment of Sumita Ray as General Counsel 46
Sep 21, 2017: Calithera Biosciences Appoints Blake Wise to Board of Directors 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables


Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calithera Biosciences Raises USD14.5 Million in Venture Financing 10
Calithera Biosciences Raises USD16 Million in Venture Financing 11
Calithera Biosciences Raises US$35 Million In Series D Financing 12
Calithera Biosciences Raises US$2 Million In Series C Financing 14
Calithera Biosciences Raises Additional US$4 Million In Series B Financing 15
Calithera Biosciences Enters into Partnership with Pfizer 17
Bristol-Myers Squibb and Calithera Biosciences Expand Agreement 18
ProTrials Research Enters into Agreement with Calithera Biosciences 19
Incyte Enters into Licensing Agreement with Calithera Biosciences 20
Calithera Biosciences Enters into Licensing Agreement with Mars Symbioscience 22
Calithera Biosciences to Raise up to USD50 Million in Public Offering of Shares 23
Calithera Biosciences Raises USD38 Million in Public Offering of Shares 24
Calithera Biosciences Raises USD80.5 Million in Public Offering of Shares 25
Calithera Biosciences Raises USD8 Million in Private Placement of Shares 27
Calithera Biosciences Raises USD80 Million in IPO 29
Calithera Biosciences Inc, Key Competitors 31
Calithera Biosciences Inc, Key Employees 32

List Of Figures


Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Calithera Biosciences Inc (CALA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

USD 250 View Report

Calithera Biosciences Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Calithera Biosciences Inc Company Profile is a detailed strategic and analytical report on Calithera Biosciences Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Arcus Biosciences Inc (RCUS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. The company develops and commercializes cancer immunotherapies. Its product pipeline includes AB928, which is in phase 1/1b trial;

USD 250 View Report

Precision Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Precision Biosciences Inc (Precision BioSciences) is a biotechnology company, which develops and commercializes gene therapy and cancer immunotherapy. The company focuses its ARCUS technology, a proprietary genome editing platform, which

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available